InvestorsHub Logo

Couch

04/04/14 3:27 PM

#101320 RE: dr_lowenstein #101315

Guess that is why Nasrat is going to get Elite bought out AFTER Elite launches several ADT products. Notice the lack of question mark dr_lowenstein.

Steges

04/04/14 4:11 PM

#101337 RE: dr_lowenstein #101315

In 2010 Pfizer purchased King Pharmaceuticals for $3.6 billion or $14.25 a share in cash (a 40 percent premium over King’s closing price the previous day). All three of the drugs (Embeda, Remoxy and Acurox) that made King such a buyout target have proven to be a disaster for Pfizer. How does this correlate to Elite? Well, Elite is going to be producing a better Embeda, in addition to a whole line of ART/ADT opioids. What do you think that does to the value of Elite? The great irony in all of this is ten years ago a friend of mine told me about ELI. Guess where he worked at the time? Pfizer.